Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Mar-24 4:12 PM View:  | Alnylam Pharmaceuticals Inc. (ALNY) | 29-Feb-24 | Option Exercise | 30,000 | $59.25 | $1,777,500.00 | 11% 266.9K to 296.9K | |
| 01-Mar-24 4:12 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 29-Feb-24 | Planned Option Sale | 30,000 | $151.34 | $4,540,070.00 | (10%) 296.9K to 266.9K | |
| 24-May-23 2:35 PM View: | Vir Biotechnology, Inc. (VIR) | 22-May-23 | Grant | 6,027 | -- | -- | 2% 248.48K to 254.51K | |
| 17-Aug-22 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Aug-22 | Option Exercise | 33,670 | $33.77 | $1,137,070.00 | 13% 266.9K to 300.57K | |
| 17-Aug-22 4:07 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Aug-22 | Planned Option Sale | 33,670 | $230.49 | $7,760,740.00 | (11%) 300.57K to 266.9K | |
| 25-May-22 6:12 PM View: | Vir Biotechnology, Inc. (VIR) | 23-May-22 | Grant | 6,405 | -- | -- | 3% 242.07K to 248.48K | |
| 11-Feb-22 10:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Feb-22 | Option Exercise | 30,000 | $11.33 | $339,900.00 | 11% 266.9K to 296.9K | |
| 11-Feb-22 10:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Feb-22 | Planned Option Sale | 30,000 | $150.00 | $4,500,000.00 | (10%) 296.9K to 266.9K | |
| 25-May-21 4:48 PM View: | Vir Biotechnology, Inc. (VIR) | 21-May-21 | Grant | 3,374 | -- | -- | 1% 238.7K to 242.07K | |
| 22-Dec-20 4:01 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Dec-20 | Gift | 235,633 | -- | -- | 88% 266.9K to 502.53K | |
| 22-Dec-20 4:01 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 07-Dec-20 | Gift | 235,633 | -- | -- | (47%) 502.53K to 266.9K | |
| 30-Nov-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Nov-20 | Option Exercise | 30,000 | $9.30 | $279,000.00 | 11% 266.9K to 296.9K | |
| 30-Nov-20 4:03 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Nov-20 | Market Option Sale (Planned) | 30,000 | $124.89 | $3,746,750.00 | (10%) 296.9K to 266.9K | |
| 13-Feb-20 4:06 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Feb-20 | Option Exercise | 30,000 | $12.48 | $374,400.00 | 11% 266.9K to 296.9K | |
| 13-Feb-20 4:06 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 12-Feb-20 | Market Option Sale (Planned) | 30,000 | $130.00 | $3,900,000.00 | (10%) 296.9K to 266.9K | |
| 20-Nov-19 4:17 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Nov-19 | Option Exercise | 15,000 | $16.43 | $246,450.00 | 6% 266.9K to 281.9K | |
| 20-Nov-19 4:17 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Nov-19 | Market Option Sale (Planned) | 15,000 | $91.71 | $1,375,660.00 | (5%) 281.9K to 266.9K | |
| 18-Oct-19 7:53 PM View: | Vir Biotechnology, Inc. (VIR) | 16-Oct-19 | Conversion | 88,888 | -- | -- | 539% 16.48K to 105.37K | |
| 18-Oct-19 7:53 PM View: | Vir Biotechnology, Inc. (VIR) | 16-Oct-19 | Conversion | 133,332 | -- | -- | 127% 105.37K to 238.7K | |
| 17-Apr-19 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Apr-19 | Option Exercise | 15,000 | $22.09 | $331,350.00 | 6% 266.9K to 281.9K | |
| 17-Apr-19 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 15-Apr-19 | Market Option Sale (Planned) | 15,000 | $88.23 | $1,323,440.00 | (5%) 281.9K to 266.9K | |
| 14-Mar-18 7:39 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Mar-18 | Option Exercise | 15,000 | $21.35 | $320,250.00 | 6% 266.9K to 281.9K | |
| 14-Mar-18 7:39 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Mar-18 | Market Option Sale (Planned) | 15,000 | $149.00 | $2,235,000.00 | (5%) 281.9K to 266.9K | 44% |
| 13-Mar-18 5:22 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Mar-18 | Option Exercise | 15,000 | $27.28 | $409,200.00 | 6% 266.9K to 281.9K | |
| 13-Mar-18 5:22 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Mar-18 | Market Option Sale (Planned) | 15,000 | $129.00 | $1,935,000.00 | (5%) 281.9K to 266.9K | 35% |
| 03-Feb-17 4:32 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Feb-17 | Option Exercise | 25,000 | $31.29 | $782,250.00 | 9% 266.9K to 291.9K | |
| 03-Feb-17 4:32 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Feb-17 | Market Option Sale (Planned) | 25,000 | $39.81 | $995,125.00 | (9%) 291.9K to 266.9K | (110%) |
| 27-Jan-17 4:10 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Jan-17 | Option Exercise | 15,000 | $31.39 | $470,850.00 | 6% 266.9K to 281.9K | |
| 27-Jan-17 4:10 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 25-Jan-17 | Market Option Sale (Planned) | 15,000 | $37.95 | $569,250.00 | (5%) 281.9K to 266.9K | (120%) |
| 20-Jan-17 4:12 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Jan-17 | Option Exercise | 15,000 | $15.91 | $238,650.00 | 6% 266.9K to 281.9K | |
| 20-Jan-17 4:12 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 18-Jan-17 | Market Option Sale (Planned) | 15,000 | $37.83 | $567,456.00 | (5%) 281.9K to 266.9K | (121%) |
| 06-Jul-16 9:23 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 06-Jul-16 | Conversion | 146,666 | -- | -- | 100% 0 to 146.67K | |
| 06-Jul-16 9:23 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 06-Jul-16 | Conversion | 120,000 | -- | -- | 82% 146.67K to 266.67K | |
| 04-Dec-15 6:11 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Dec-15 | Option Exercise | 30,000 | $14.28 | $428,400.00 | 11% 266.9K to 296.9K | |
| 04-Dec-15 6:11 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 04-Dec-15 | Market Option Sale (Planned) | 30,000 | $109.00 | $3,270,000.00 | (10%) 296.9K to 266.9K | 23% |
| 03-Jun-15 4:49 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Jun-15 | Acquisition (other) | 25,844 | -- | -- | 10% 266.9K to 292.74K | |
| 03-Jun-15 4:49 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 01-Jun-15 | Disposition (other) | 25,844 | -- | -- | (9%) 292.74K to 266.9K | |
| 15-Oct-14 4:54 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Oct-14 | Option Exercise | 110,000 | $7.71 | $847,800.00 | 41% 266.9K to 376.9K | |
| 15-Oct-14 4:54 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Oct-14 | Market Option Sale (Planned) | 110,000 | $85.00 | $9,350,000.00 | (29%) 376.9K to 266.9K | 2% |
| 15-Oct-14 4:54 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Jul-14 | Acquisition (other) | 21,890 | -- | -- | 8% 266.9K to 288.79K | |
| 15-Oct-14 4:54 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 09-Jul-14 | Disposition (other) | 21,890 | -- | -- | (8%) 288.79K to 266.9K | |
| 03-Jan-14 4:47 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 02-Jul-13 | Acquisition (other) | 38,837 | -- | -- | 8% 492.2K to 531.04K | |
| 03-Jan-14 4:47 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 02-Jul-13 | Disposition (other) | 38,837 | -- | -- | (7%) 531.04K to 492.2K | |
| 24-Jan-13 4:48 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Jan-13 | Private Purchase | 4,967 | $20.13 | $99,985.70 | 2% 261.93K to 266.9K | |
| 23-Feb-12 5:19 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 21-Feb-12 | Private Purchase | 9,302 | $10.75 | $99,996.50 | 4% 252.63K to 261.93K | |
| 04-Jun-10 4:56 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-May-10 | Acquisition (other) | 29,600 | -- | -- | 12% 252.63K to 282.23K | |
| 04-Jun-10 4:56 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-May-10 | Acquisition (other) | 105,400 | -- | -- | 37% 282.23K to 387.63K | |
| 04-Jun-10 4:56 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-May-10 | Disposition (other) | 29,600 | -- | -- | (8%) 387.63K to 358.03K | |
| 04-Jun-10 4:56 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 27-May-10 | Disposition (other) | 105,400 | -- | -- | (29%) 358.03K to 252.63K | |
| 05-Jun-09 11:07 AM View: | Biogen Idec Inc. (BIIB) | 03-Jun-09 | Grant | 2,245 | -- | -- | < 1% 468.03K to 470.28K |